Edition:
United Kingdom

Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.25USD
22 Feb 2018
Change (% chg)

$0.07 (+5.93%)
Prev Close
$1.18
Open
$1.15
Day's High
$1.60
Day's Low
$1.15
Volume
1,515,077
Avg. Vol
47,123
52-wk High
$4.66
52-wk Low
$0.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 18.90 -1.349
Jun '17 23.36 -2.003
Mar '17 19.15 -4.666
FY 2016 Dec '16 13.88 -1.686
Sep '16 7.00 1.302
Jun '16 7.79 -1.732
Mar '16 5.03 -1.535
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 27.50 27.50 27.50 --
Quarter Ending Jun-18 1 27.50 27.50 27.50 --
Year Ending Dec-18 2 133.25 156.50 110.00 --
Earnings (per share)
Quarter Ending Mar-18 1 -2.17 -2.17 -2.17 --
Quarter Ending Jun-18 1 -1.59 -1.59 -1.59 --
Year Ending Dec-18 2 -5.15 -3.54 -6.76 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 2.39 0.90 0.89
Price to Sales (TTM) 0.50 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 48.46 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 199.78 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago 128.58 78.63 5.59
Sales - 5 Yr. Growth Rate 50.27 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.63 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -31.87 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.36 1.80 2.18
Current Ratio (MRQ) 2.73 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.65 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -131.60 -- --
EBITD - 5 Yr. Avg -255.08 -572.68 10.86
Operating Margin (TTM) -103.57 -717.10 4.64
Operating Margin - 5 Yr. Avg. -246.13 -594.00 6.26
Pre-Tax Margin (TTM) -120.56 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -246.37 -597.35 6.60
Net Profit Margin (TTM) -120.77 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -247.63 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 480,197 22,602,121 855,668,157
Net Income/Employee (TTM) -579,932 2,968,747 100,655,595
Receivable Turnover (TTM) 12.01 20.14 5.78
Inventory Turnover (TTM) 1.41 2.36 3.35
Asset Turnover (TTM) 0.24 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.59 -1.05 10.98
Return on Assets - 5 Yr. Avg. -29.98 -0.57 12.37
Return on Investment (TTM) -33.37 1.66 14.43
Return on Investment - 5 Yr. Avg. -35.15 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -118.72 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 37.82 114.24 50.27
EPS (TTM) % 67.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Orexigen Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -10.82 -13.90 15 53
13 Week -30.41 -33.79 10 62
26 Week -22.26 -28.17 27 77
52 Week -35.62 -45.44 25 50
YTD 18.39 3.97 57 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.25%
# of Holders: 59
Total Shares Held: 8,168,382
3 Mo. Net Change: 1,144,504
# New Positions: 10
# Closed Positions: 8
# Increased Positions: 19
# Reduced Positions: 20
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.